It has a 42.76 P/E ratio. The Company's segments include EMEA, United Kingdom, Asia Pacific and Americas.
Stock research analysts at Credit Suisse have GBX 1175.00 PT on RPC Group PLC (LON:RPC). GBX 239.77's average target is 15.72% above currents GBX 207.2 stock price.
About 375,205 shares traded or 21.86% up from the average. It has underperformed by 27.76% the S&P500.
JRP Group PLC (LON:JRP) had its price target lowered by Barclays PLC from GBX 177 ($2.23) to GBX 168 ($2.11) in a research note released on Tuesday. Therefore 78% are positive.
Over the last twelve months Segro PLC's stock price has increased from 406.5 to 487, a change of 19.8%. Admiral Group PLC had 128 analyst reports since August 17, 2015 according to SRatingsIntel.
Credit Suisse Group AG upgraded shares of Pagegroup PLC (LON:PAGE) to a neutral rating in a research report sent to investors on Tuesday. HSBC maintained it with "Hold" rating and GBX 625 target in Wednesday, September 16 report. HSBC Holdings plc has a 12-month low of $28.62 and a 12-month high of $44.18. Jefferies maintained NMC Health PLC (LON:NMC) on Wednesday, April 19 with "Buy" rating. The firm earned "Buy" rating on Monday, September 26 by Needham. Royal Bank of Canada restated an underperform rating and set a GBX 775 ($9.62) target price on shares of Dunelm Group plc in a report on Thursday, January 12th. The stock of RPC Group PLC (LON:RPC) has "Outperform" rating given on Wednesday, August 5 by RBC Capital Markets. The rating was maintained by Barclays Capital on Thursday, October 6 with "Overweight". Finally, Royal Bank of Canada reiterated an outperform rating and issued a GBX 200 ($2.52) price objective on shares of JRP Group PLC in a report on Friday, March 17th. The company has market cap of 4.66 billion GBP. The Firm offers a range of consumer products and technical components for the packaging and non-packaging markets. It has a 20.28 P/E ratio.
Several other analysts have also recently commented on the company. They expect $0.50 earnings per share, up 4.17% or $0.02 from last year's $0.48 per share. After $0.17 actual EPS reported by Headwaters Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Ratings analysis reveals 33% of Anika Therapeutics's analysts are positive. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. The lowest target is $20 while the high is $24.25. The stock was purchased at an average price of GBX 625 ($7.76) per share, with a total value of £197,043.75 ($244,683.66). MSA was included in 7 notes of analysts from July 24, 2015. The firm earned "Add" rating on Friday, March 31 by Numis Securities. The firm has "Buy" rating by Investec given on Monday, February 1. DA Davidson downgraded the shares of HW in report on Tuesday, November 22 to "Neutral" rating. The company was maintained on Friday, February 26 by Northland Capital. The stock has "Hold" rating by Liberum Capital on Tuesday, October 27.
Sls Management Llc holds 5.82% of its portfolio in Vonage Holdings Corp. for 626,344 shares. New Vernon Investment Management Llc owns 72,125 shares or 5.4% of their USA portfolio. Moreover, Tieton Capital Management Llc has 3.43% invested in the company for 641,453 shares. Cowen Group Inc., a New York-based fund reported 2.39 million shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.